<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Resverlogix Corp. — News on 6ix</title>
<link>https://6ix.com/company/resverlogix-corp</link>
<description>Latest news and press releases for Resverlogix Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 16 Apr 2026 11:15:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/resverlogix-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835fb2578dffbe2df131999.webp</url>
<title>Resverlogix Corp.</title>
<link>https://6ix.com/company/resverlogix-corp</link>
</image>
<item>
<title>Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-corp-announces-filing-of-annual-filings-and-revocation-of-mcto</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-corp-announces-filing-of-annual-filings-and-revocation-of-mcto</guid>
<pubDate>Thu, 16 Apr 2026 11:15:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - April 16, 2026) - Resverlogix Corp.&#xA0;(TSX: RVX)&#xA0;("Re...</description>
</item>
<item>
<title>Resverlogix Corp. Announces Issuance of MCTO by ASC</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-corp-announces-issuance-of-mcto-by-asc-8</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-corp-announces-issuance-of-mcto-by-asc-8</guid>
<pubDate>Thu, 02 Apr 2026 11:15:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - April 2, 2026) - Resverlogix Corp. (TSX: RVX)&#xA0;("Resverlo...</description>
</item>
<item>
<title>Resverlogix Corp. Provides Bi-Weekly MCTO Status Update</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-corp-provides-bi-weekly-mcto-status-update</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-corp-provides-bi-weekly-mcto-status-update</guid>
<pubDate>Tue, 31 Mar 2026 23:09:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - March 31, 2026) - Resverlogix Corp.&#xA0;(TSX: RVX)&#xA0;("Re...</description>
</item>
<item>
<title>Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-delay-in-filing-of-annual-financial-statements-aif-and-mdanda</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-delay-in-filing-of-annual-financial-statements-aif-and-mdanda</guid>
<pubDate>Wed, 18 Mar 2026 02:49:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - March 17, 2026) - Resverlogix Corp.&#xA0;(TSX: RVX)&#xA0;("Re...</description>
</item>
<item>
<title>Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-closes-dollar28-million-shares-for-interest-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-closes-dollar28-million-shares-for-interest-private-placement</guid>
<pubDate>Thu, 19 Feb 2026 00:00:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - February 18, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix") announced today that it has closed a $2.8 million shares-for-interest private placement with an immediate family member (the "Subscriber") of Resverlogix's Chairman and CEO. Under the terms of the shares-for-interest transaction, the Subscriber subscribed for 28,000,000 common shares at CAD$0.10 per share for aggregate proceeds of CAD$2.8 million. After giving effect to the transaction, the...</description>
</item>
<item>
<title>Resverlogix Appoints Bradley Glass to Board of Directors</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-appoints-bradley-glass-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-appoints-bradley-glass-to-board-of-directors</guid>
<pubDate>Tue, 18 Nov 2025 22:15:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - November 18, 2025) - Resverlogix Corp.&#xA0;(TSX: RVX)&#xA0;(...</description>
</item>
<item>
<title>Resverlogix Announces Voting Results from the 2025 Meeting of Shareholders</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-voting-results-from-the-2025-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-voting-results-from-the-2025-meeting-of-shareholders</guid>
<pubDate>Mon, 30 Jun 2025 21:31:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - June 30, 2025) - Resverlogix Corp.&#xA0;(TSX: RVX)&#xA0;("Res...</description>
</item>
<item>
<title>Numerous Independent Groups Presented Data that Supports Apabetalone's Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024</title>
<link>https://6ix.com/company/resverlogix-corp/news/numerous-independent-groups-presented-data-that-supports-apabetalones-potential-cardioprotective-benefits-at-european-society-of-cardiology-congress-2024</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/numerous-independent-groups-presented-data-that-supports-apabetalones-potential-cardioprotective-benefits-at-european-society-of-cardiology-congress-2024</guid>
<pubDate>Tue, 03 Sep 2024 14:15:00 GMT</pubDate>
<description>Numerous GLP-1 RA and SGLT2i presentations touted their clinical results, providing continued exc...</description>
</item>
<item>
<title>Resverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture Extension</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-voting-results-from-the-2024-meeting-of-shareholders-and-closing-of-debenture-extension</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-voting-results-from-the-2024-meeting-of-shareholders-and-closing-of-debenture-extension</guid>
<pubDate>Wed, 31 Jul 2024 22:30:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - July 31, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix",...</description>
</item>
<item>
<title>Resverlogix Provides Update Regarding Two-Year Extension of Debenture and Elimination of Conversion Privileges</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-provides-update-regarding-two-year-extension-of-debenture-and-elimination-of-conversion-privileges</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-provides-update-regarding-two-year-extension-of-debenture-and-elimination-of-conversion-privileges</guid>
<pubDate>Tue, 16 Jul 2024 11:15:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - July 16, 2024) - Resverlogix Corp. (TSX: RVX)&#xA0;("Resverlo...</description>
</item>
<item>
<title>Resverlogix Announces Updated Annual and Special Meeting of Shareholders</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-updated-annual-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-updated-annual-and-special-meeting-of-shareholders</guid>
<pubDate>Tue, 28 May 2024 21:00:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - May 28, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" o...</description>
</item>
<item>
<title>Resverlogix Announces Two-Year Extension of Debenture and Elimination of Conversion Privileges</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-two-year-extension-of-debenture-and-elimination-of-conversion-privileges</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-two-year-extension-of-debenture-and-elimination-of-conversion-privileges</guid>
<pubDate>Mon, 13 May 2024 21:00:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - May 13, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" o...</description>
</item>
<item>
<title>Resverlogix Announces Change to Its Board of Directors</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-change-to-its-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-change-to-its-board-of-directors</guid>
<pubDate>Thu, 22 Feb 2024 00:00:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - February 21, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlog...</description>
</item>
<item>
<title>Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-publication-of-its-40th-scientific-journal-article-on-apabetalones-potential-therapeutic-benefits</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-publication-of-its-40th-scientific-journal-article-on-apabetalones-potential-therapeutic-benefits</guid>
<pubDate>Thu, 11 Jan 2024 12:15:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - January 11, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogi...</description>
</item>
<item>
<title>Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-publishes-on-apabetalones-potential-for-the-treatment-of-fshd-the-third-most-common-muscular-dystrophy</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-publishes-on-apabetalones-potential-for-the-treatment-of-fshd-the-third-most-common-muscular-dystrophy</guid>
<pubDate>Wed, 04 Oct 2023 11:12:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - October 4, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix...</description>
</item>
<item>
<title>Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-a-favorable-outlook-based-on-new-cardiovascular-disease-treatment-guidelines-for-patients-with-type-2-diabetes</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-a-favorable-outlook-based-on-new-cardiovascular-disease-treatment-guidelines-for-patients-with-type-2-diabetes</guid>
<pubDate>Tue, 29 Aug 2023 11:15:00 GMT</pubDate>
<description>Amsterdam, Netherlands and Calgary, Alberta--(Newsfile Corp. - August 29, 2023) - Resverlogix Cor...</description>
</item>
<item>
<title>Resverlogix Announces Warrant Repricing and One-Year Extension</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-warrant-repricing-and-one-year-extension</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-warrant-repricing-and-one-year-extension</guid>
<pubDate>Thu, 29 Jun 2023 22:00:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - June 29, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" ...</description>
</item>
<item>
<title>Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-voting-results-from-the-2023-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-voting-results-from-the-2023-meeting-of-shareholders</guid>
<pubDate>Tue, 20 Jun 2023 22:12:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - June 20, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix",...</description>
</item>
<item>
<title>Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-new-insights-into-the-mechanism-of-apabetalones-cardioprotective-benefit-in-chronic-kidney-disease-patients</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-new-insights-into-the-mechanism-of-apabetalones-cardioprotective-benefit-in-chronic-kidney-disease-patients</guid>
<pubDate>Mon, 12 Jun 2023 11:15:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - June 12, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix")...</description>
</item>
<item>
<title>Resverlogix Announces One-Year Extension of Debenture</title>
<link>https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-one-year-extension-of-debenture</link>
<guid isPermaLink="true">https://6ix.com/company/resverlogix-corp/news/resverlogix-announces-one-year-extension-of-debenture</guid>
<pubDate>Mon, 20 Mar 2023 11:15:00 GMT</pubDate>
<description>Calgary, Alberta--(Newsfile Corp. - March 20, 2023) - Resverlogix Corp. (TSX: RVX) ("Resverlogix"...</description>
</item>
</channel>
</rss>